Ashvattha Therapeutics Appoints Robert J. Dempsey as Interim CEO
By Daniella Parra Ashvattha Therapeutics has appointed Robert J. Dempsey as Interim CEO, tapping an ophthalmology...
By Daniella Parra Ashvattha Therapeutics has appointed Robert J. Dempsey as Interim CEO, tapping an ophthalmology...
Download the Complete Report Here By Brandon Hornback Whether a first-time gun owner or avid...
By Karen Roman Vinson & Elkins said Tigist Kassahun joined the firm as partner and...
By Karen Roman Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it started a global product license...
Comprehensive platform leverages city’s unique advantages to capture emerging market opportunities across culture, entertainment, and...
By Pious Jung As CJ ENM enters its fourth decade, we are once again betting...
IPO Edge hosted a fireside chat on Oct. 2 at Nasdaq MarketSite with Enzo Villani,...
Download the Complete Report Here By Rayk Riechmann Playing interest rates is notoriously difficult, especially...
Tech Edge hosted a fireside chat on Oct. 1 from the floor of the New...
Download the Complete Report Here By Rayk Riechmann After closing several successful SPAC transactions across...